Noninvasive Characterization of Human Glymphatics and Meningeal Lymphatics in an in vivo Model of Blood–Brain Barrier Leakage

Abstract

Objective To evaluate human glymphatics and meningeal lymphatics noninvasively. Methods This prospective study implemented 3‐dimensional (3D) isotropic contrast‐enhanced T2 fluid‐attenuated inversion recovery (CE‐T2‐FLAIR) imaging with a 3T magnetic resonance machine to study cerebral glymphatics and meningeal lymphatics in patients with reversible cerebral vasoconstriction syndrome (RCVS) with (n = 92) or without (n = 90) blood–brain barrier (BBB) disruption and a diseased control group with cluster headache (n = 35). The contrast agent gadobutrol (0.2mmol/kg [0.2ml/kg]) was administered intravenously in all study subjects. Results In total, 217 patients (182 RCVS, 35 cluster headache) were analyzed and separated into 2 groups based on the presence or absence of visible gadolinium (Gd) leakage. Para‐arterial tracer enrichment was clearly depicted in those with overt BBB disruption, while paravenous and parasinus meningeal contrast enrichment was evident in both groups. Paravenous and parasinus contrast enrichment remained in RCVS patients in the remission stage and in cluster headache patients, suggesting that these meningeal lymphatic channels were universal anatomical structures rather than being phase‐ or condition‐specific. Additionally, we demonstrated nodular leptomeningeal enhancement in 32.3% of participants, which might represent potential lymphatic reservoirs. Four selected RCVS patients who received consecutive contrasted 3D isotropic FLAIR imaging after gadobutrol administration showed that the Gd persisted for at least 54 minutes and was completely cleared within 18 hours. Interpretation This large‐scale in vivo study successfully demonstrated the putative human para‐arterial glymphatic transports and meningeal lymphatics by clear depiction of para‐arterial, parasinus, and paravenous meningeal contrast enrichment using high‐resolution 3D isotropic CE‐T2‐FLAIR imaging noninvasively; this technique may serve as a basis for further studies to delineate clinical relevance of glymphatic clearance. ANN NEUROL 2021;89:111–124

The Glymphatic System: A Novel Therapeutic Target for Stroke Treatment

“…Furthermore, surgical ligation of the cervical lymphatic vessels enhanced tracers accumulation into the meningeal lymphatic network and prevented tracers from retention in dcLNs. These findings are supported by multiple studies using MRI and diffusion of radiolabeled tracers (Eide and Vatnehol, 2018;Alvesx de Lima et al, 2020;Zhou et al, 2020;Wu et al, 2021). These observations further indicate that meningeal lymphatics are the major efflux route for macromolecules, immune cells, and CSF/ISF.…”

Glymphatic Dysfunction in Patients With Ischemic Stroke

“…The mechanism of the glymphatic function recovery is not known, and we speculate that it may be the result of glymphatic pathway remodeling. As described in glioma-bearing mice, the glymphatic function is increased by extensive growth of meningeal lymphatic vessels, which is downstream of the glymphatic pathway ( Zhou Y. et al, 2020 ; Wu et al, 2021 ). The glymphatic pathway remodeling helps fluid clearance and reduction of peritumoral brain edema ( Hu et al, 2020 ).…”

Cerebral Edema Formation After Stroke: Emphasis on Blood–Brain Barrier and the Lymphatic Drainage System of the Brain

“…In addition, paravascular AQP4 channels, which are highly polarized to paravascular astrocytic endfeet (Mathiisen et al, 2010), facilitate bulk ISF solute clearance from the parenchyma (Iliff et al, 2012). The putative glymphatic transports have also been successfully demonstrated in humans with BBB disruption using non-invasive, highresolution 3D isotropic contrast-enhanced T2 fluid-attenuated inversion recovery imaging (Wu et al, 2020).…”